p53 modifications: exquisite decorations of the powerful guardian
Open accessThe DOI matches its Crossref record; 207 of the 209 references it cites were found in a registry or an index.
Abstract
The last 40 years have witnessed how p53 rose from a viral binding protein to a central factor in both stress responses and tumor suppression. The exquisite regulation of p53 functions is of vital importance for cell fate decisions. Among the multiple layers of mechanisms controlling p53 function, posttranslational modifications (PTMs) represent an efficient and precise way. Major p53 PTMs include phosphorylation, ubiquitination, acetylation, and methylation. Meanwhile, other PTMs like sumoylation, neddylation, O-GlcNAcylation, adenosine diphosphate (ADP)-ribosylation, hydroxylation, and β-hydroxybutyrylation are also shown to play various roles in p53 regulation. By independent action or interaction, PTMs affect p53 stability, conformation, localization, and binding partners. Deregulation of the PTM-related pathway is among the major causes of p53-associated developmental disorders or diseases, especially in cancers. This review focuses on the roles of different p53 modification types and shows how these modifications are orchestrated to produce various outcomes by modulating p53 activities or targeted to treat different diseases caused by p53 dysregulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Acetylation’s role in transcription goes further via mediating the stability of various transcription factors including HIF-1α [74] and p53 [75].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–207 of 207
Duan, L., Perez, R. E., Chen, L., Blatter, L. A., & Maki, C. G. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx051 · Cited by 24
Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53
Lee, E., Oh, W., Song, H. P., & Kim, W. K. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.7.077 · Cited by 22
Targeting HAUSP in both p53 wildtype and p53-mutant tumors
Tavana, O., Sun, H., & Gu, W. J. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1456293 · Cited by 20
Self-citationp53 and MDM2: their Yin-Yang intimacy
Lu, H. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx003 · Cited by 15
Decrease of mitochondrial p53 during late apoptosis is linked to its dephosphorylation on serine 20
Castrogiovanni, C., Vandaudenard, M., Waterschoot, B., Backer, O. D., & Dumont, P. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1070978 · Cited by 13
Pellino1 specifically binds to phospho-Thr18 of p53 and is recruited to sites of DNA damage
Dai, L. X., Lin, J., Said, A. B., Yau, Y. H., Shochat, S. G., Carrillo, D. R., Sun, K., Chandrasekaran, R., Sze, S. K., Lescar, J., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.095 · Cited by 12
Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99
Lee, X. A., Verma, C. S., & Sim, A. Y. L. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25310 · Cited by 9
Cited by
p53 in ferroptosis regulation: The new weapon for the old guardian
Liu, Y., & Gu, W. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00943-y · Cited by 540
Self-citationUnderstanding the complexity of p53 in a new era of tumor suppression
Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 495
Self-citationZhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4
Chen, D., Chu, B., Yang, X., Liu, Z., Jin, Y., Kon, N., Rabadan, R., Jiang, X., Stockwell, B. R., & Gu, W. (2021) · Nature Communications · doi:10.1038/s41467-021-23902-6 · Cited by 348
Self-citationGain-of-function mutant p53 in cancer progression and therapy
Zhang, C., Liu, J., Xu, D., Zhang, T., Hu, W., & Feng, Z. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa040 · Cited by 334
Metadata
- Authors
- Liu, Y., Tavana, O., & Gu, W.
- Affiliations
- Columbia University (US)
- Herbert Irving Comprehensive Cancer Center (US)
- Corresponding author
- Gu, Wei
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07
- Volume
- 11
- Issue
- 7
- Pages
- 564-577
- ISSN
- 1674-2788 (ISSN-L)
- 1759-4685
- PMC
- PMC6736412
- OpenAlex
- W2961184804
- Cited by
- 392
- References
- 209
- Citations by year
- 2026: 31 · 2025: 47 · 2024: 49 · 2023: 73 · 2022: 83 · 2021: 63 · 2020: 40 · 2019: 5
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Molecular Cell Biology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute of the National Institutes of Health (5R01CA193890, 5R01CA085533, 5R01CA190477, 5R01CA216884)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- p53, post-translational modification, phosphorylation, ubiquitination, acetylation, methylation, SUMOylation, neddylation, O-GlcNAcylation, ADP-ribosylation, hydroxylation, β-hydroxybutyrylation, p53 stabilization, tumor suppression, stress response, cancer, developmental disorders
- MeSH terms
- Animals, Humans, Neoplasms, Protein Processing, Post-Translational, Tumor Suppressor Protein p53, History, 20th Century, History, 21st Century, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.